$TXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 10x Genomics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in 10x Genomics, Inc.. Get notifications about new insider transactions in 10x Genomics, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 36,364 | 32,000 | 73,000 | 36.6 K to 73 K (+99.26 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 36,364 | 32,000 | 0 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 159.40 | 7,167 | 1,142,386 | 36,636 | 43.8 K to 36.6 K (-16.36 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 158.64 | 6,368 | 1,010,223 | 43,803 | 50.2 K to 43.8 K (-12.69 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 157.48 | 5,845 | 920,452 | 50,171 | 56 K to 50.2 K (-10.43 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 156.45 | 8,189 | 1,281,143 | 56,016 | 64.2 K to 56 K (-12.75 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 155.54 | 8,074 | 1,255,815 | 64,205 | 72.3 K to 64.2 K (-11.17 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 154.56 | 6,023 | 930,887 | 72,279 | 78.3 K to 72.3 K (-7.69 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 1.07 | 5,302 | 5,673 | 78,302 | 73 K to 78.3 K (+7.26 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 36,364 | 32,000 | 73,000 | 36.6 K to 73 K (+99.26 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 579,000 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 159.51 | 2,100 | 334,977 | 34,608 | 36.7 K to 34.6 K (-5.72 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 158.85 | 3,176 | 504,513 | 36,708 | 39.9 K to 36.7 K (-7.96 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 157.70 | 2,211 | 348,684 | 39,884 | 42.1 K to 39.9 K (-5.25 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 156.52 | 3,606 | 564,404 | 42,095 | 45.7 K to 42.1 K (-7.89 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 155.54 | 3,807 | 592,148 | 45,701 | 49.5 K to 45.7 K (-7.69 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 154.52 | 2,100 | 324,492 | 49,508 | 51.6 K to 49.5 K (-4.07 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 579,000 | |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 159.51 | 2,100 | 334,977 | 34,608 | 36.7 K to 34.6 K (-5.72 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 158.85 | 3,176 | 504,513 | 36,708 | 39.9 K to 36.7 K (-7.96 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 157.70 | 2,211 | 348,684 | 39,884 | 42.1 K to 39.9 K (-5.25 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 156.52 | 3,606 | 564,404 | 42,095 | 45.7 K to 42.1 K (-7.89 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 155.54 | 3,807 | 592,148 | 45,701 | 49.5 K to 45.7 K (-7.69 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 154.52 | 2,100 | 324,492 | 49,508 | 51.6 K to 49.5 K (-4.07 %) |
Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 11.48 | 9,583 | 110,013 | 10,417 | |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 450,159 | |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 11.48 | 9,583 | 110,013 | 30,357 | 20.8 K to 30.4 K (+46.13 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 154.82 | 100 | 15,482 | 20,774 | 20.9 K to 20.8 K (-0.48 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 154.14 | 300 | 46,241 | 20,874 | 21.2 K to 20.9 K (-1.42 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 152.08 | 400 | 60,833 | 21,174 | 21.6 K to 21.2 K (-1.85 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 151.22 | 800 | 120,977 | 21,574 | 22.4 K to 21.6 K (-3.58 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 150.22 | 1,200 | 180,261 | 22,374 | 23.6 K to 22.4 K (-5.09 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 149.43 | 1,100 | 164,371 | 23,574 | 24.7 K to 23.6 K (-4.46 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 148.08 | 200 | 29,616 | 24,674 | 24.9 K to 24.7 K (-0.80 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 146.88 | 1,476 | 216,793 | 24,874 | 26.4 K to 24.9 K (-5.60 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 145.90 | 1,902 | 277,501 | 26,350 | 28.3 K to 26.4 K (-6.73 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 145.03 | 1,100 | 159,528 | 28,252 | 29.4 K to 28.3 K (-3.75 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 142.49 | 400 | 56,994 | 29,352 | 29.8 K to 29.4 K (-1.34 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 141.25 | 1,022 | 144,357 | 29,752 | 30.8 K to 29.8 K (-3.32 %) |
Mar 10 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 30,774 | 20.8 K to 30.8 K (+48.14 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 178.98 | 200 | 35,796 | 465,991 | 466.2 K to 466 K (-0.04 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 178.16 | 300 | 53,447 | 466,191 | 466.5 K to 466.2 K (-0.06 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 177.23 | 1,202 | 213,035 | 466,491 | 467.7 K to 466.5 K (-0.26 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 176.14 | 2,304 | 405,821 | 467,693 | 470 K to 467.7 K (-0.49 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 175.38 | 3,094 | 542,624 | 469,997 | 473.1 K to 470 K (-0.65 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 174.14 | 400 | 69,656 | 473,091 | 473.5 K to 473.1 K (-0.08 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 892 | 10,240 | 126,671 | |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 9,108 | 45,904 | 105,407 | |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 178.98 | 200 | 35,796 | 880,468 | 880.7 K to 880.5 K (-0.02 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 177.99 | 600 | 106,792 | 880,668 | 881.3 K to 880.7 K (-0.07 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 176.99 | 1,410 | 249,557 | 881,268 | 882.7 K to 881.3 K (-0.16 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 175.92 | 4,815 | 847,046 | 882,678 | 887.5 K to 882.7 K (-0.54 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 175.22 | 2,575 | 451,192 | 887,493 | 890.1 K to 887.5 K (-0.29 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 174.15 | 400 | 69,660 | 890,068 | 890.5 K to 890.1 K (-0.04 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 892 | 10,240 | 890,468 | 889.6 K to 890.5 K (+0.10 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 9,108 | 45,904 | 889,576 | 880.5 K to 889.6 K (+1.03 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 460,159 | |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 178.49 | 500 | 89,247 | 20,774 | 21.3 K to 20.8 K (-2.35 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 177.50 | 910 | 161,525 | 21,274 | 22.2 K to 21.3 K (-4.10 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 176.51 | 2,777 | 490,171 | 22,184 | 25 K to 22.2 K (-11.13 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 175.53 | 5,213 | 915,027 | 24,961 | 30.2 K to 25 K (-17.28 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 174.18 | 600 | 104,509 | 30,174 | 30.8 K to 30.2 K (-1.95 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 30,774 | 20.8 K to 30.8 K (+48.14 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 179.02 | 607 | 108,662 | 36,636 | 37.2 K to 36.6 K (-1.63 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 177.68 | 2,998 | 532,671 | 37,243 | 40.2 K to 37.2 K (-7.45 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 176.65 | 6,322 | 1,116,781 | 40,241 | 46.6 K to 40.2 K (-13.58 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 175.74 | 18,374 | 3,229,091 | 46,563 | 64.9 K to 46.6 K (-28.30 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 174.90 | 4,749 | 830,601 | 64,937 | 69.7 K to 64.9 K (-6.81 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 173.79 | 700 | 121,650 | 69,686 | 70.4 K to 69.7 K (-0.99 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 596,000 | |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 178.92 | 200 | 35,783 | 34,608 | 34.8 K to 34.6 K (-0.57 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 177.86 | 900 | 160,073 | 34,808 | 35.7 K to 34.8 K (-2.52 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 176.95 | 2,700 | 477,751 | 35,708 | 38.4 K to 35.7 K (-7.03 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 175.94 | 8,451 | 1,486,839 | 38,408 | 46.9 K to 38.4 K (-18.03 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 175.25 | 4,003 | 701,522 | 46,859 | 50.9 K to 46.9 K (-7.87 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 173.99 | 746 | 129,796 | 50,862 | 51.6 K to 50.9 K (-1.45 %) |
Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
Feb 01 2021 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 8,675,167 | 0 | 0 | |
Feb 01 2021 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Sell | S | 78.25 | 1,000,000 | 78,250,000 | 5,617,583 | 6.6 M to 5.6 M (-15.11 %) |
Feb 01 2021 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Sell | S | 74.48 | 568 | 42,305 | 6,617,583 | 6.6 M to 6.6 M (-0.01 %) |
Feb 01 2021 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Sell | J | 0.00 | 1,527,241 | 0 | 6,618,151 | 8.1 M to 6.6 M (-18.75 %) |
Feb 01 2021 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Sell | J | 0.00 | 619,306 | 0 | 8,055,861 | 8.7 M to 8.1 M (-7.14 %) |
Feb 01 2021 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Buy | C | 0.00 | 8,675,167 | 0 | 8,675,167 | 0 to 8.7 M |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 182.78 | 376 | 68,726 | 473,491 | 473.9 K to 473.5 K (-0.08 %) |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 181.49 | 900 | 163,343 | 473,867 | 474.8 K to 473.9 K (-0.19 %) |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 180.27 | 1,206 | 217,406 | 474,767 | 476 K to 474.8 K (-0.25 %) |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 179.28 | 1,608 | 288,285 | 475,973 | 477.6 K to 476 K (-0.34 %) |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 178.31 | 1,110 | 197,925 | 477,581 | 478.7 K to 477.6 K (-0.23 %) |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 176.57 | 900 | 158,910 | 478,691 | 479.6 K to 478.7 K (-0.19 %) |
Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 175.79 | 1,400 | 246,103 | 479,591 | 481 K to 479.6 K (-0.29 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 141.61 | 100 | 14,161 | 480,991 | 481.1 K to 481 K (-0.02 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 140.94 | 900 | 126,847 | 481,091 | 482 K to 481.1 K (-0.19 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 139.88 | 5,200 | 727,386 | 481,991 | 487.2 K to 482 K (-1.07 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 138.91 | 1,300 | 180,588 | 487,191 | 488.5 K to 487.2 K (-0.27 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 114,515 | |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 141.91 | 200 | 28,382 | 880,468 | 880.7 K to 880.5 K (-0.02 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 140.83 | 1,523 | 214,486 | 880,668 | 882.2 K to 880.7 K (-0.17 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 139.91 | 6,277 | 878,233 | 882,191 | 888.5 K to 882.2 K (-0.71 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 139.08 | 2,000 | 278,160 | 888,468 | 890.5 K to 888.5 K (-0.22 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 890,468 | 880.5 K to 890.5 K (+1.14 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 470,159 | |
Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 141.91 | 200 | 28,382 | 20,774 | 21 K to 20.8 K (-0.95 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 140.78 | 1,764 | 248,331 | 20,974 | 22.7 K to 21 K (-7.76 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 139.92 | 6,036 | 844,525 | 22,738 | 28.8 K to 22.7 K (-20.98 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 139.08 | 2,000 | 278,152 | 28,774 | 30.8 K to 28.8 K (-6.50 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 30,774 | 20.8 K to 30.8 K (+48.14 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 141.58 | 1,200 | 169,896 | 70,386 | 71.6 K to 70.4 K (-1.68 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 140.62 | 6,825 | 959,744 | 71,586 | 78.4 K to 71.6 K (-8.70 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 139.83 | 22,026 | 3,079,814 | 78,411 | 100.4 K to 78.4 K (-21.93 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 138.78 | 3,699 | 513,346 | 100,437 | 104.1 K to 100.4 K (-3.55 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 613,000 | |
Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 141.77 | 400 | 56,708 | 34,608 | 35 K to 34.6 K (-1.14 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 140.74 | 3,135 | 441,211 | 35,008 | 38.1 K to 35 K (-8.22 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 139.89 | 10,465 | 1,463,947 | 38,143 | 48.6 K to 38.1 K (-21.53 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 138.97 | 3,000 | 416,908 | 48,608 | 51.6 K to 48.6 K (-5.81 %) |
Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 5.04 | 13,333 | 67,198 | 111,667 | |
Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.20 | 20,312 | 24,374 | 4,688 | |
Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 5.04 | 13,333 | 67,198 | 34,608 | 21.3 K to 34.6 K (+62.67 %) |
Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.20 | 20,312 | 24,374 | 21,275 | 963 to 21.3 K (+2,109.24 %) |
Dec 28 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 1.20 | 28,000 | 33,600 | 172,000 | |
Dec 28 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 8,636 | 7,600 | 36,364 | |
Dec 28 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 1.20 | 28,000 | 33,600 | 104,136 | 76.1 K to 104.1 K (+36.78 %) |
Dec 28 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 8,636 | 7,600 | 76,136 | 67.5 K to 76.1 K (+12.79 %) |
Dec 28 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 19,841 | 99,999 | 480,159 | |
Dec 28 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 19,841 | 99,999 | 20,774 | 933 to 20.8 K (+2,126.58 %) |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 962 | 1,154 | 108,898 | |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 2,667 | 2,854 | 0 | |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 962 | 1,154 | 880,468 | 879.5 K to 880.5 K (+0.11 %) |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 2,667 | 2,854 | 879,506 | 876.8 K to 879.5 K (+0.30 %) |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Gift | G | 0.00 | 15,000 | 0 | 876,839 | 861.8 K to 876.8 K (+1.74 %) |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Gift | G | 0.00 | 15,000 | 0 | 89,960 | 105 K to 90 K (-14.29 %) |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Gift | G | 0.00 | 104,960 | 0 | 104,960 | 0 to 105 K |
Dec 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Gift | G | 0.00 | 104,960 | 0 | 861,839 | 966.8 K to 861.8 K (-10.86 %) |
Dec 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 151.24 | 300 | 45,371 | 488,491 | 488.8 K to 488.5 K (-0.06 %) |
Dec 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 149.36 | 801 | 119,633 | 488,791 | 489.6 K to 488.8 K (-0.16 %) |
Dec 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 148.51 | 3,098 | 460,068 | 489,592 | 492.7 K to 489.6 K (-0.63 %) |
Dec 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 147.68 | 2,200 | 324,905 | 492,690 | 494.9 K to 492.7 K (-0.44 %) |
Dec 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 146.78 | 1,101 | 161,606 | 494,890 | 496 K to 494.9 K (-0.22 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,000,000 | 0 | 5,790,422 | |
Dec 10 2020 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Sell | J | 0.00 | 268,692 | 0 | 2,037,825 | 2.3 M to 2 M (-11.65 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Sell | J | 0.00 | 731,308 | 0 | 2,306,517 | 3 M to 2.3 M (-24.07 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Buy | C | 0.00 | 3,000,000 | 0 | 3,037,825 | 37.8 K to 3 M (+7,931.26 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 5,790,422 | |
Dec 10 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 93,487 | 0 | 215,291 | 121.8 K to 215.3 K (+76.75 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 268,692 | 0 | 2,037,825 | 2.3 M to 2 M (-11.65 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 731,308 | 0 | 2,306,517 | 3 M to 2.3 M (-24.07 %) |
Dec 10 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 3,000,000 | 0 | 3,037,825 | 37.8 K to 3 M (+7,931.26 %) |